ProSeek Bio

ProSeek Bio

Biotechnology Research

Empowering women's health starting with ovarian cancer screening test

About us

Empowering cancer screening through new glycoprotein biomarker-based blood tests that are simple for patients and doctors, but sophisticated and cost-effective in the clinical laboratory. ProSeek Bio is securing exclusive rights to commercialise the ovarian cancer biomarkers discovered by Associate Professor Michelle Hill's laboratory at QIMR Berghofer Medical Research Institute, using the lectin magnetic bead array (LeMBA)-mass spectrometry platform developed earlier in her laboratory at The University of Queensland.

Industry
Biotechnology Research
Company size
1 employee
Headquarters
Brisbane
Type
Privately Held
Founded
2023
Specialties
biomarkers, proteomics, in vitro diagnostic, clinical diagnostic, glycoprotein, research, cancer biomarkers, cancer screening, cancer testing, ovarian cancer, and women's health

Locations

Updates

Similar pages